ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,970.84
-1.11%
US Tech 100
20,897.20
-1.35%
다우존스 지수
42,992.21
-0.77%
Bitcoin
95,244.48
1.15%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Connect Biopharma Holdings Inc (CNTB)

  7. Connect Biopharma Holdings Inc (CNTB) 뉴스

CNTB

Connect Biopharma (CNTB)

Connect Biopharma Holdings Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CNTB
일자시간출처헤드라인심볼기업
2024/12/2406:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
2024/10/1520:30GlobeNewswire Inc.Attovia Therapeutics Appoints Chief Financial OfficerNASDAQ:CNTBConnect Biopharma Holdings Inc
2024/09/1021:00GlobeNewswire Inc.Connect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024NASDAQ:CNTBConnect Biopharma Holdings Inc
2024/09/0706:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
2024/09/0605:05GlobeNewswire Inc.Connect Biopharma Reports First Half 2024 Financial Results and Provides Business UpdateNASDAQ:CNTBConnect Biopharma Holdings Inc
2024/08/0306:13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
2024/06/1305:47Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
2024/02/2811:00Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CNTBConnect Biopharma Holdings Inc
2024/02/1406:30Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:CNTBConnect Biopharma Holdings Inc
2024/02/1406:27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CNTBConnect Biopharma Holdings Inc
2024/02/1406:18Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CNTBConnect Biopharma Holdings Inc
2024/02/1306:50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
2023/12/1220:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
2023/11/2120:13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
2023/11/0204:57Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
2023/10/2105:44Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
2023/09/1305:47Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
2023/09/1219:13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
2023/07/1506:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
2023/06/2405:32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTBConnect Biopharma Holdings Inc
2023/06/0205:25Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTBConnect Biopharma Holdings Inc
2023/04/1205:59Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CNTBConnect Biopharma Holdings Inc
2023/04/1205:05GlobeNewswire Inc.Connect Biopharma Reports Full Year 2022 Financial Results and Provides Business UpdateNASDAQ:CNTBConnect Biopharma Holdings Inc
2023/03/2205:53Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTBConnect Biopharma Holdings Inc
2023/03/1903:40Business WireConnect Biopharma CBP-201 Atopic Dermatitis China Pivotal Study Showed Rapid Relief of Patient SymptomsNASDAQ:CNTBConnect Biopharma Holdings Inc
2023/03/1805:05Business WireConnect Biopharma CBP-201 Atopic Dermatitis Global Phase 2b Data Showed Rapid and Sustained Improvement Across all Body RegionsNASDAQ:CNTBConnect Biopharma Holdings Inc
2023/03/0622:15Business WireConnect Biopharma CBP-201 Atopic Dermatitis Abstracts from Two Trials Accepted for Presentation at the American Academy of Dermatology (AAD) Annual MeetingNASDAQ:CNTBConnect Biopharma Holdings Inc
2023/02/1420:33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNTBConnect Biopharma Holdings Inc
2023/02/1000:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNTBConnect Biopharma Holdings Inc
2023/02/0920:07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTBConnect Biopharma Holdings Inc
 검색 관련기사 보기:NASDAQ:CNTB

최근 히스토리

NYSE
MCD
McDonalds
SPI
SP500
S&P 500
AMEX
XLF
Financial Select Sector
AMEX
XLV
Health Care Select Sector
NYSE
AXP
American Express
USI
USTECH100
US Tech 100
NASDAQ
AMZN
Amazon.com
COIN
ETHUSD
Ethereum
FX
USDJPY
US Dollar vs Yen
NYSE
KO
Coca Cola
NASDAQ
MSFT
Microsoft
COIN
AVAXUSD
Avalanche
NYSE
NKE
Nike
COIN
BTCUSD
Bitcoin
AMEX
XLE
Energy Select Sector SPDR
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유